# Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

> **NCT00139178** · PHASE4 · COMPLETED · sponsor: **Danish HIV Research Group** · enrollment: 100 (—)

## Conditions studied

- HIV Associated Lipodystrophy Syndrome.
- HIV
- Hypercholesterolemia
- Lipoatrophy

## Interventions

- **DRUG:** Different HAART regimens

## Key facts

- **NCT ID:** NCT00139178
- **Lead sponsor:** Danish HIV Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 100 (—)
- **Last updated:** 2005-09-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139178, "Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00139178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*